2021 global health spending reached a record $9.8 trillion (10.3% of GDP), with mid-cap healthcare stocks attracting hedge funds.

Global health spending reached a record $9.8 trillion in 2021, accounting for 10.3% of global GDP. Despite the residual impact of COVID-19, the healthcare sector continues to innovate, leveraging AI and other technologies to streamline clinical development processes and predict treatment outcomes. Mid-cap healthcare stocks such as Xenon Pharmaceuticals, Intra-Cellular Therapies, and Exact Sciences Corporation have caught the attention of hedge funds due to their growth potential and defensive industry status.

May 28, 2024
7 Articles